Search IconSearch
April 27, 2020/News Releases

Cleveland Clinic Appoints Timothy Chan, M.D., Ph.D., as Director of Center for Immunotherapy and Precision Immuno-Oncology

Media Downloads

images: 0

video: 0

audio: 0

text: 0

Timothy Chan, M.D., Ph.D.

Timothy Chan, M.D., Ph.D., has been appointed director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic.

A renowned immuno-oncology and cancer genomics expert, Dr. Chan leads the new center which brings together multidisciplinary experts from across the Cleveland Clinic enterprise to advance research and treatment related to the rapidly growing field of immuno-oncology.

The center will comprise four arms, including a Cleveland cell therapy program in collaboration with the Case Comprehensive Cancer Center, and will recruit national and international experts in computational science, immunotherapy and cancer immunology. The new center will initially have sites in Cleveland and the soon-to-open Cleveland Clinic Florida Research and Innovation Center in Port St. Lucie, Florida, both focused on immunotherapy research and developmental therapeutics.

Dr. Chan will also collaborate with experts in the new Center for Global and Emerging Pathogens Research, which is focused on broadening understanding of immunology and microbial pathogenesis with the goal of improving treatment for a variety of diseases, including virus-induced cancers.

“Immunotherapy is the future of research in cancer and various other diseases and Cleveland Clinic has made it a priority by establishing this new center,” said Serpil Erzurum, M.D., chair of Cleveland Clinic’s Lerner Research Institute. “The Center for Immunotherapy and Precision Immuno-Oncology will empower clinicians and scientists throughout the enterprise to advance personalized cancer care and breakthrough immunotherapy research at Cleveland Clinic.”

Dr. Chan joins Cleveland Clinic from Memorial Sloan Kettering Cancer Center and Weill Cornell School of Medicine, where he leads the Immunogenomics and Precision Oncology Platform and was a tenured professor, the PaineWebber Chair, and the Translational Oncology Division chair. He is an internationally recognized expert in precision immuno-oncology and a pioneer in using genomics to determine which patients will respond best to certain types of immunotherapies. He has published over 200 articles in peer-reviewed journals, has made landmark discoveries in his field, and has received numerous awards, including the National Cancer Institute Outstanding Investigator Award in 2018.

“Innovation in precision immunotherapy is one of the most exciting areas in cancer research,” said Brian Bolwell, M.D., chairman of Taussig Cancer Institute, Cleveland Clinic Cancer Center. “The addition of Dr. Chan, a pioneer in cancer genomics, and the new center’s focus on research and clinical trials will strengthen our ability to provide advanced treatment options for our patients.”

Dr. Chan also joins the leadership of the National Center for Regenerative Medicine of Case Western Reserve University. Dr. Chan is also on staff in the Genomic Medicine Institute of the Lerner Research Institute; and the Department of Radiation Oncology of the Taussig Cancer Institute.

Dr. Chan earned his M.D. and Ph.D. in genetics from Johns Hopkins University, where he also completed a residency in radiation oncology and a postdoctoral fellowship in the division of tumor biology. He is board certified in radiation oncology and is an elected member of the Association of American Physicians (AAP).

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/CleClinicNews. News and resources available at newsroom.clevelandclinic.org.

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

Latest from the Newsroom